SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-001762
Filing Date
2008-02-27
Accepted
2008-02-26 19:02:14
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2182915z10-k.htm 10-K 905454
2 EXHIBIT 10.34 a2182915zex-10_34.htm EX-10.34 22000
3 EXHIBIT 10.35 a2182915zex-10_35.htm EX-10.35 91916
4 EXHIBIT 10.36 a2182915zex-10_36.htm EX-10.36 30222
5 EXHIBIT 23.1 a2182915zex-23_1.htm EX-23.1 2875
6 EXHIBIT 31.1 a2182915zex-31_1.htm EX-31.1 7275
7 EXHIBIT 31.2 a2182915zex-31_2.htm EX-31.2 7307
8 EXHIBIT 32.1 a2182915zex-32_1.htm EX-32.1 5567
9 G512114.JPG g512114.jpg GRAPHIC 30731
10 G46719.JPG g46719.jpg GRAPHIC 31452
  Complete submission text file 0001047469-08-001762.txt   1160053
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 08644228
SIC: 2834 Pharmaceutical Preparations